跳至主要内容
临床试验/CTRI/2024/05/067752
CTRI/2024/05/067752尚未招募不适用

A Randomized Controlled Trial Comparing Efficacy of Amniotic Membrane Graft versus 0.025% Mitomycin C with Conjunctival Autograft for the treatment of Primary Pterygium

Veer Chandra Singh Garhwali Government Institute of Medical Science and Research1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年1月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
120
试验地点
1
主要终点
Recurrence rate in conjunctival autograft with 0.02% mitomycin c versus amniotic membrane graft

研究概览

简要总结

To see the effectiveness in patients having primary pterygium underwent  Amniotic Membrane Graft versus 0.025% Mitomycin C with Conjunctival Autograft.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients diagnosed with primary pterygium.
  • Adults (18 years and older).

排除标准

  • Patients with recurrent pterygium, severe ocular conditions, such as advanced glaucoma, corneal dystrophy, or significant ocular surface disease.
  • Combined surgical procedures at the time of surgery like trabeculectomy, cataract surgery.
  • Macular degeneration or any other retinal pathology were excluded.
  • With systemic connective tissue disorders.
  • Inability to give informed consent.

结局指标

主要结局

Recurrence rate in conjunctival autograft with 0.02% mitomycin c versus amniotic membrane graft

时间窗: Comparison of the effectiveness will be notice at 1 week and 1 month

次要结局

  • Recurrence rate in conjunctival autograft with 0.02% mitomycin c versus amniotic membrane graft(Effectiveness of recurrence after 2 months)

研究者

研究点 (1)

Loading locations...

相似试验